News Detail
New Delhi, 29 Aug 2024: Over 60 percent fixed-dose combination (FDC) drugs consumed for mental health disorders in India are “unapproved” and lack therapeutic benefit, an analysis has found amid a major crackdown on FDC drugs by the country’s apex drug regulator......
View Details
Source : The Print
fixed-dose combination (FDC)
mental health disorders
unapproved
Journal of Pharmaceutical Policy and Practice
Fixed dose combination
psychiatry
psychotropic
psychopharmacology
pharmacoepidemiology
India
Related News
- Gilead Sciences agrees to license new HIV prevention drug to 120 countries (06-10-2024)
- Five sentenced to 10 year rigorous imprisonment for smuggling Ketamine (06-10-2024)
- Treated by fake doctor without MBBS who was working as RMO for five years (06-10-2024)
- 'Create rare diseases fund': Delhi HC to Centre (06-10-2024)
- 10th pass Ramkishore of Bandikui became doctor by putting photo on the documents of Ramkishore of Dungarpur (06-10-2024)
- Fake call centres selling Viagra, duping people in loan fraud busted, 36 arrested (05-10-2024)
- SHEOHAR: Raid on illegal nursing home and medical shop, medicines worth Rs 5 lakh seized (05-10-2024)
- Iron tablets prime target of illegal med producers (05-10-2024)
- DEA Issues Warning About Illegal Online Pharmacies (05-10-2024)
- NCC-PVPI writes not to prescribe/use Nimesulide formulations in Children under 12 years (04-10-2024)